Buscar
01/01/2024
The ileorectal anastomosis after a total colectomy is a feasible and valid surgical alternative in the treatment of inflammatory bowel disease
Tapiolas, I, Mañosa, M, Troya, J, Vela, S, Pares, D, Mesonero, F, Valera, P, Riestra, S, Iglesias, E, Rodríguez-González, E, Guardiola, J, López, SG, Carpio, D, Vega, P, Arranz, MDM, Ramos, L, Busquets, D, Sierra, M, Montiel, PM, Sicilia, B, Ricart, E, Planella, EG, Huguet, JM, Vera, I, Gomollon, F, Rivero, M, De Castro, L, de Acosta, MB, Lago, IR, Gisbert, JP, Sepulcre, MFG, Calvet, X, Bermejo, F, Calle, JLP, Gutierrez, A, Lucendo, AJ, Vilafranca, MDCM, Llavat, MN, Calafat, M, Domenech, E. The ileorectal anastomosis after a total colectomy is a feasible and valid surgical alternative in the treatment of inflammatory bowel disease. Journal of Crohns & Colitis. 2024; 18DOI:. PMID:. IF:8.700(Q1/1D).
01/01/2024
Clinical characteristics, risk factors and management of patients with inflammatory bowel disease and hidradenitis suppurativa: a nationwide multicenter study of the GETECCU ENEIDA registry
Velázquez, LM, De Francisco, R, Herreros, B, Yagüe, C, Bujanda, L, Calvet, X, Ponferrada, A, Aguas, M, Rodríguez-Moranta, F, Marin-Jiménez, I, Catala, L, Gomollon, F, Huguet, J, Mesonero, F, Monfort, D, Sierra, M, Igualada, L, Ricart, E, González-Vivó, M, García, MJ, Hernandez-Camba, A, Elorza, A, Martín, LZS, Ramos, L, Arranz, MDM, Ruiz-Nuñez, I, Martinez-Montiel, P, Soto, P, Roig, C, Molina, ML, Mañona, M, Taxonera, C, Barreiro-de Acosta, M, Gisbert, JP, Ramírez, P, Lorente, R, Zabana, Y, Botella, B, Domènech, E, Gutierrez-Casbas, A. Clinical characteristics, risk factors and management of patients with inflammatory bowel disease and hidradenitis suppurativa: a nationwide multicenter study of the GETECCU ENEIDA registry. Journal of Crohns & Colitis. 2024; 18DOI:. PMID:. IF:8.700(Q1/1D).
01/01/2024
Therapeutic Management And Risk Of Colectomy In Patients With Acute Severe Ulcerative Colitis And Previous Exposure To Anti-Tnf Drugs. A Cohort Study Of Geteccu
Gismero, FM, Lopez-García, A, Miranda-Bautista, J, de Célix, CR, Marin-Jiménez, I, Suárez, C, Martin-Cardona, A, Fuentes, E, Mínguez, A, Castaño, A, Roig, C, Fernández-Clotet, A, Gargallo-Puyuelo, CJ, Herrero, BA, García, MJ, Segarra-Ortega, JX, Rodríguez-Grau, MC, Romero-Salazar, FL, Olmella, I, Martín-Rodríguez, D, Vivo, MG, Ponferrada, A, Baston-Rey, I, Benítez, JM, Reygosa, C, González, EAL, Delgado-Guillena, PG, Torrealba, L, Hernández-Camba, A, Bernal, L, Pinero, G, Brunet, E, Irabien, M, Marques-Camí, M, Zabana, Y, Gutiérrez, A. Therapeutic Management And Risk Of Colectomy In Patients With Acute Severe Ulcerative Colitis And Previous Exposure To Anti-Tnf Drugs. A Cohort Study Of Geteccu. Journal of Crohns & Colitis. 2024; 18DOI:. PMID:. IF:8.700(Q1/1D).
01/01/2024
Characteristics and management of pyoderma gangrenosum and erythema nodosum in patients with inflammatory bowel disease: PIONOSO multicenter study
Rodríguez-Lago, I, Vela, M, Ordás, I, de Francisco, R, Martín-Arranz, MD, Calafat, M, Taxonera, C, Mesonero, F, Fuentes-Valenzuela, E, Granja, A, Ponferrada-Díaz, A, Varela, P, Zabana, Y, Madero, L, López-Cauce, B, Carrillo, M, Laredo, V, Brunet, E, Rivero, M, Polo, C, Gisbert, JP, Rodríguez, C, Suria, C, Lorente, R, Elorza, A, Sicilia, B, Muñoz-Villafranca, MDC, Mínguez, A, Ferreiro-Iglesias, R, Pajares, R, Castro-Poceiro, J, Surís, G, Roig, C, Mena, R, Lucendo, AJ, de la Peña, L, Iyo, E, Ber, Y, Domènech, E, Barreiro-de Acosta, M. Characteristics and management of pyoderma gangrenosum and erythema nodosum in patients with inflammatory bowel disease: PIONOSO multicenter study. Journal of Crohns & Colitis. 2024; 18DOI:. PMID:. IF:8.700(Q1/1D).
01/01/2024
Frequency and effectiveness of dose de-escalation of biologic therapy in Inflammatory Bowel Disease: The RAINBOW-IBD study of ENEIDA
De Célix, CR, Ricart, E, Martín-Arranz, MD, de Francisco, R, Barrio, J, Mesonero, F, Gomollón, F, de Castro, L, Ramos, L, García-López, S, Arias, L, Mañosa, M, Iglesias, E, Calvet, X, Pascual, I, Casanova, MJ, Pérez-Calle, JL, Giordano, A, Sierra, M, Vera, I, Navarro-Llavat, M, Lorente, R, Piqueras, M, Rivero, M, Guardiola, J, Esteve, M, Coronel, AF, Rodríguez-Lago, I, Ponferrada, A, Ber, Y, Tardillo, C, Márquez, L, Carpio, D, Taxonera, C, Bermejo, F, Busquets, D, Camps, B, Domènech, E, Chaparro, M, Gisbert, JP. Frequency and effectiveness of dose de-escalation of biologic therapy in Inflammatory Bowel Disease: The RAINBOW-IBD study of ENEIDA. Journal of Crohns & Colitis. 2024; 18DOI:. PMID:. IF:8.700(Q1/1D).
01/01/2024
Effect of the HLA-DQA1*05 allele on the efficacy of ustekinumab in patients with Crohn's Disease. Multicenter study based on the ENEIDA registry of GETECCU.
Capón, JG, Iborra, M, Padró, A, de la Peña, L, Serra, K, Martin-Arranz, MD, Domènech, E, Fernandez, A, Mesonero, F, Gonzalez-Muñoza, C, Ferreiro-Iglesias, R, Navarro, P, Martín-Cardona, A, Sicilia, B, Sierra-Ausin, M, Calvet, X, Marquez, L, de Francisco, R, Cañete, F, Gutierrez, A, García-López, S, Rivero, M, Hinojosa, J, Iglesias-Flores, E, Nos, P, Riestra, S, Bosca-Watts, M, Zabana, Y, Castro, B, Barreiro, M, Garcia-Planella, E, Ricart, E, De Francisco, R, Suris, G, Ruiz-Cerulla, A, Rodriguez-Alonso, L, Orobitg, J, Rodríguez-Moranta, F. Effect of the HLA-DQA1*05 allele on the efficacy of ustekinumab in patients with Crohn's Disease. Multicenter study based on the ENEIDA registry of GETECCU.. Journal of Crohns & Colitis. 2024; 18DOI:. PMID:. IF:8.700(Q1/1D).
01/01/2024
The need for culture in tegumentary leishmaniasis diagnosis in Bolivia: A comparative evaluation of four parasitological techniques using two sampling methods
Torrico M.C., Ballart C., Fernández-Arévalo A., Solano M., Rojas E., Abras A., Gonzales F., Mamani Y., Arnau A., Lozano D., Gascón J., Picado A., Torrico F., Muñoz C., Gállego M.. The need for culture in tegumentary leishmaniasis diagnosis in Bolivia: A comparative evaluation of four parasitological techniques using two sampling methods. ACTA TROPICA. 2024; 250DOI:10.1016/j.actatropica.2023.107092. PMID:38065375. IF:2.500(Q1/1D).
01/01/2024
Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response
Ortiz, MA, Diaz-Torne, C, De Agustin, JJ, Estrada, P, Reina, D, Hernandez, MV, Sang, HY, Zamora, C, Canto, E, Corominas, H, Vidal, S. Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response. Biomolecules. 2024; 14(1)DOI:10.3390/biom14010001. PMID:38275742. IF:4.800(Q1/3D).